SEARCH

SEARCH BY CITATION

References

  • Bach, D., Pich, S., Soriano, F.X., Vega, N., Baumgartner, B., Oriola, J., Daugaard, J.R., Lloberas, J., Camps, M., Zierath, J.R., Rabasa-Lhoret, R., Wallberg-Henriksson, H., Laville, M., Palacin, M., Vidal, H., Rivera, F., Brand, M. & Zorzano, A. (2003) Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. Journal of Biological Chemistry, 278, 1719017197.
  • Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189199.
  • Boultwood, J., Pellagatti, A., Nikpour, M., Pushkaran, B., Fidler, C., Cattan, H., Littlewood, T.J., Malcovati, L., Della Porta, M.G., Jadersten, M., Killick, S., Giagounidis, A., Bowen, D., Hellstrom-Lindberg, E., Cazzola, M. & Wainscoat, J.S. (2008) The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. PLoS ONE, 3, e1970.
  • Busque, L., Zhu, J., DeHart, D., Griffith, B., Willman, C., Carroll, R., Black, P.M. & Gilliland, D.G. (1994) An expression based clonality assay at the human androgen receptor locus (HUMARA) on chromosome X. Nucleic Acids Research, 22, 697698.
  • Cairo, G. & Recalcati, S. (2007) Iron-regulatory proteins: molecular biology and pathophysiological implications. Expert Reviews in Molecular Medicine, 9, 113.
  • Cavadini, P., Biasiotto, G., Poli, M., Levi, S., Verardi, R., Zanella, I., Derosas, M., Ingrassia, R., Corrado, M. & Arosio, P. (2007) RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload. Blood, 109, 35523559.
  • Cazzola, M., Invernizzi, R., Bergamaschi, G., Levi, S., Corsi, B., Travaglino, E., Rolandi, V., Biasiotto, G., Drysdale, J. & Arosio, P. (2003) Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. Blood, 101, 19962000.
  • Chen, G., Zeng, W., Miyazato, A., Billings, E., Maciejewski, J.P., Kajigaya, S., Sloand, E.M. & Young, N.S. (2004) Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities. Blood, 104, 42104218.
  • Craven, S.E., French, D., Ye, W., De Sauvage, F. & Rosenthal, A. (2005) Loss of Hspa9b in zebrafish recapitulates the ineffective hematopoiesis of the myelodysplastic syndrome. Blood, 105, 35283534.
  • Germing, U., Gattermann, N., Aivado, M., Hildebrandt, B. & Aul, C. (2000) Two types of acquired idiopathic sideroblastic anaemia (AISA): a time-tested distinction. British Journal of Haematology, 108, 724728.
  • Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. & Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 20792088.
  • Hellstrom-Lindberg, E., Ahlgren, T., Beguin, Y., Carlsson, M., Carneskog, J., Dahl, I.M., Dybedal, I., Grimfors, G., Kanter-Lewensohn, L., Linder, O., Luthman, M., Lofvenberg, E., Nilsson-Ehle, H., Samuelsson, J., Tangen, J.M., Winqvist, I., Oberg, G., Osterborg, A. & Ost, A. (1998) Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. Blood, 92, 6875.
  • Hoefsloot, L.H., Van Amelsvoort, M.P., Broeders, L.C., Van Der Plas, D.C., Van Lom, K., Hoogerbrugge, H., Touw, I.P. & Lowenberg, B. (1997) Erythropoietin-induced activation of STAT5 is impaired in the myelodysplastic syndrome. Blood, 89, 16901700.
  • Hofmann, W.K., De Vos, S., Komor, M., Hoelzer, D., Wachsman, W. & Koeffler, H.P. (2002) Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood, 100, 35533560.
  • Hu, B., Liao, C., Millson, S.H., Mollapour, M., Prodromou, C., Pearl, L.H., Piper, P.W. & Panaretou, B. (2005) Qri2/Nse4, a component of the essential Smc5/6 DNA repair complex. Molecular Microbiology, 55, 17351750.
  • Irizarry, R.A., Hobbs, B., Collin, F., Beazer-Barclay, Y.D., Antonellis, K.J., Scherf, U. & Speed, T.P. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4, 249264.
  • Jadersten, M., Montgomery, S.M., Dybedal, I., Porwit-MacDonald, A. & Hellstrom-Lindberg, E. (2005) Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF. Blood, 106, 803811.
  • Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J.W. (2001) WHO Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Scientific Publication, Lyon, France.
  • Kanter-Lewensohn, L., Hellstrom-Lindberg, E., Kock, Y., Elmhorn-Rosenborg, A. & Ost, A. (1996) Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry. European Journal of Haematology, 56, 124129.
  • Kaul, S.C., Takano, S., Reddel, R.R., Mitsui, Y. & Wadhwa, R. (2000) Transcriptional inactivation of p53 by deletions and single amino acid changes in mouse mot-1 protein. Biochemical and Biophysical Research Communications, 279, 602606.
  • Li, L.C. & Dahiya, R. (2002) MethPrimer: designing primers for methylation PCRs. Bioinformatics, 18, 14271431.
  • Livak, K.J. & Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402408.
  • Ljung, T., Back, R. & Hellstrom-Lindberg, E. (2004) Hypochromic red blood cells in low-risk myelodysplastic syndromes: effects of treatment with hemopoietic growth factors. Haematologica, 89, 14461453.
  • Lorente, A., Mueller, W., Urdangarin, E., Lazcoz, P., Von Deimling, A. & Castresana, J.S. (2008) Detection of methylation in promoter sequences by melting curve analysis-based semiquantitative real time PCR. BMC Cancer, 8, 61.
  • Millot, G.A., Svinarchuk, F., Lacout, C., Vainchenker, W. & Dumenil, D. (2001) The granulocyte colony-stimulating factor receptor supports erythroid differentiation in the absence of the erythropoietin receptor or Stat5. British Journal of Haematology, 112, 449458.
  • Novotna, B., Neuwirtova, R., Siskova, M. & Bagryantseva, Y. (2008) DNA instability in low-risk myelodysplastic syndromes: refractory anemia with or without ring sideroblasts. Human Molecular Genetics, 17, 21442149.
  • Ohtsuka, R., Abe, Y., Fujii, T., Yamamoto, M., Nishimura, J., Takayanagi, R. & Muta, K. (2007) Mortalin is a novel mediator of erythropoietin signaling. European Journal of Haematology, 79, 114125.
  • Pang, Q., Keeble, W., Christianson, T.A., Faulkner, G.R. & Bagby, G.C. (2001) FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha-mediated cytotoxicity. EMBO Journal, 20, 44784489.
  • Pellagatti, A., Cazzola, M., Giagounidis, A.A., Malcovati, L., Porta, M.G., Killick, S., Campbell, L.J., Wang, L., Langford, C.F., Fidler, C., Oscier, D., Aul, C., Wainscoat, J.S. & Boultwood, J. (2006) Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype. Blood, 108, 337345.
  • Ribeil, J.A., Zermati, Y., Vandekerckhove, J., Cathelin, S., Kersual, J., Dussiot, M., Coulon, S., Moura, I.C., Zeuner, A., Kirkegaard-Sorensen, T., Varet, B., Solary, E., Garrido, C. & Hermine, O. (2007) Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. Nature, 445, 102105.
  • Schmidt-Mende, J., Tehranchi, R., Forsblom, A.M., Joseph, B., Christensson, B., Fadeel, B., Zhivotovsky, B. & Hellstrom-Lindberg, E. (2001) Granulocyte colony-stimulating factor inhibits Fas-triggered apoptosis in bone marrow cells isolated from patients with refractory anemia with ringed sideroblasts. Leukemia, 15, 742751.
  • Shu, C.W., Sun, F.C., Cho, J.H., Lin, C.C., Liu, P.F., Chen, P.Y., Chang, M.D., Fu, H.W. & Lai, Y.K. (2008) GRP78 and Raf-1 cooperatively confer resistance to endoplasmic reticulum stress-induced apoptosis. Journal of Cellular Physiology, 215, 627635.
  • Steensma, D.P., Hecksel, K.A., Porcher, J.C. & Lasho, T.L. (2007) Candidate gene mutation analysis in idiopathic acquired sideroblastic anemia (refractory anemia with ringed sideroblasts). Leukemia Research, 31, 623628.
  • Sternberg, A., Killick, S., Littlewood, T., Hatton, C., Peniket, A., Seidl, T., Soneji, S., Leach, J., Bowen, D., Chapman, C., Standen, G., Massey, E., Robinson, L., Vadher, B., Kaczmarski, R., Janmohammed, R., Clipsham, K., Carr, A. & Vyas, P. (2005) Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome. Blood, 106, 29822991.
  • Sugioka, R., Shimizu, S. & Tsujimoto, Y. (2004) Fzo1, a protein involved in mitochondrial fusion, inhibits apoptosis. Journal of Biological Chemistry, 279, 5272652734.
  • Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Scientific Publication, Lyon, France.
  • Tang, M., Wei, X., Guo, Y., Breslin, P., Zhang, S., Zhang, S., Wei, W., Xia, Z., Diaz, M., Akira, S. & Zhang, J. (2008) TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice. Journal of Experimental Medicine, 205, 16111619.
  • Tehranchi, R., Fadeel, B., Forsblom, A.M., Christensson, B., Samuelsson, J., Zhivotovsky, B. & Hellstrom-Lindberg, E. (2003) Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors. Blood, 101, 10801086.
  • Tehranchi, R., Invernizzi, R., Grandien, A., Zhivotovsky, B., Fadeel, B., Forsblom, A.M., Travaglino, E., Samuelsson, J., Hast, R., Nilsson, L., Cazzola, M., Wibom, R. & Hellstrom-Lindberg, E. (2005) Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes. Blood, 106, 247253.
  • Tonon, L., Bergamaschi, G., Dellavecchia, C., Rosti, V., Lucotti, C., Malabarba, L., Novella, A., Vercesi, E., Frassoni, F. & Cazzola, M. (1998) Unbalanced X-chromosome inactivation in haemopoietic cells from normal women. British Journal of Haematology, 102, 9961003.
  • Wadhwa, R., Takano, S., Robert, M., Yoshida, A., Nomura, H., Reddel, R.R., Mitsui, Y. & Kaul, S.C. (1998) Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member. Journal of Biological Chemistry, 273, 2958629591.
  • Zhang, K. & Kaufman, R.J. (2006) Protein folding in the endoplasmic reticulum and the unfolded protein response. Handbook of Experimental Pharmacology, 172, 6991.